Mar 17 Preparing for the Next Pandemic Requires New, Effective Antibiotic Treatments to Fight Infection #SquashSuperbugs Calls for Action Now on Antimicrobial Resistance March 17, 2021 (Washington, D.C.) As we mark one-year of the global...
Mar 9 Squash Superbugs Day of Action The Partnership to Fight Infectious Disease (PFID) launched last year with the goal of advancing awareness on the growing crisis of...
Feb 24 No Regrets: From Trial Participant to Vaccinated, One Person’s Journey in the Fight Against COVID-19 When I told family, friends, and colleagues that I was going to participate in a COVID-19 vaccine clinical trial, they used many words to...
Feb 2 The Time is Now for a National Pandemic Preparedness Strategy By: Ken Thorpe With COVID-19 vaccines rolling out in all 50 states, there’s reason for optimism. In addition to that light at the end of...
Dec 17, 2020 Leading Health Care and Infectious Disease Experts Join Together to Discuss COVID-19 Vaccine Safety Partnership to Fight Infectious Disease Convenes National Conversation Moderated by BBC World News America’s Katty Kay; Launches...
Dec 14, 2020 Vaccinating America Against COVID-19 - Leading Experts Address Key Questions Submit your question here >
Dec 3, 2020 Partnership to Fight Infectious Disease Urges Prioritization of Pandemic Preparedness Strategy Open Letter Outlines Key Components to Address Impact of Future Health Emergencies December 03, 2020 11:38 AM WASHINGTON--(BUSINESS...
Dec 3, 2020 A Letter to President-Elect Biden on Pandemic Preparedness December 2, 2020 Dear President-elect Biden: The Partnership to Fight Infectious Disease congratulates you on your election as the 46th...
Nov 18, 2020 Growing Acknowledgement in Congress on Need to Combat AMR as Part of Preparing for the Next Pandemic The Partnership to Fight Infectious Disease (PFID) is encouraged by the growing acknowledgement among policymakers that addressing the...
Oct 14, 2020 Industry Voices—Voters want action on antibiotic resistance October 13, 2020 by Celinda Lake, Lake Research Partners, Ed Goeas, The Tarrance Group The COVID-19 pandemic is far from over, but the...
